Interactions of family history of breast cancer with radiotherapy in relation to the risk of breast cancer recurrence

Danmeng Li, Volker Mai, Travis Gerke, Susan Mengel Pinney, Lusine Yaghjyan

Abstract

Purpose: We examined associations between a family history of breast cancer and the risk of breast cancer recurrence in women who received or did not receive radiotherapy.

Methods: Our study included 2,440 women enrolled in the Breast Cancer Registry of Greater Cincinnati. Information on breast cancer risk factors, including detailed family history of breast cancer, characteristics of the primary tumor, treatment received, and recurrence status was collected at baseline and via updates. Associations between a family history of breast cancer and the risk of breast cancer recurrence were examined separately in women treated with and without radiotherapy using survival analysis.

Results: Over an average follow-up time of 8.78 years, we found no associations between a family history of breast cancer and the risk of breast cancer recurrence among women with a history of radiotherapy (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.75–1.23). Among women who did not receive radiotherapy, the total number of relatives with breast cancer was positively associated with the risk of breast cancer recurrence (HR, 1.21; 95% CI, 1.00–1.47). We found no interactions of radiotherapy with family history (p-interaction >0.05).

Conclusion: Radiotherapy for a primary breast cancer in women with a family history of breast cancer does not increase risk of breast cancer recurrence. If these findings are replicated in future studies, the results may translate into an important health message for breast cancer survivors with a family history of breast cancer.

Published In Journal of Breast Cancer
Date Dec 1, 2017
DOI 10.4048/jbc.2017.20.4.333
Links

Citation

Li D, Mai V, Gerke TA, Pinney SM, Yaghjyan L. Interactions of family history of breast cancer with radiotherapy in relation to the risk of breast cancer recurrence. J Breast Cancer 2017; 20(4): 333--339. PMID: 29285037 PMCID: PMC5743992.